Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Online Thinking-Skills Tests for People With Parkinson's Disease

Tests whether online thinking-skills testing is practical for people with Parkinson's disease.

Plain-language title generated from the registry record
Registry title: Cognitive Testing Online in Parkinson's Disease

Key facts

Where
Montreal, CanadaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with Parkinson's disease diagnosed by a neurologist, and healthy people with no neurological illness. It tests thinking skills online.

Age
45 Years to 90 Years
Sex
All sexes can join.

Main reasons for not taking part

  • Psychotic spectrum disorders
  • Active uncontrolled depression
  • Advanced dementia (needing help with daily activities such as dressing or bathing)
  • Major stroke or major head injury
  • Epilepsy needing anti-seizure medications

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 90 years old?

Source: NCT05025254, who can take part

Where in Canada

  • McGill University Health CentreMontreal, CanadaContact: Madeleine SharpTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
McGill University
Trial code
NCT05025254
Record updated
27 August 2021
Original description
This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research. Thus a large part of this pilot study will be to demonstrate feasibility and reliability, and use this experience to develop a feasible protocol for ongoing research. The specific short-term objectives are:Read full original descriptionShow less

Deep Cognitive Endophenotyping of Parkinson's Disease: A Platform Development and Pilot Study

This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research. Thus a large part of this pilot study will be to demonstrate feasibility and reliability, and use this experience to develop a feasible protocol for ongoing research. The specific short-term objectives are:

1. To establish the feasibility of performing large-scale deep cognitive phenotyping using online cognitive testing. 2. To demonstrate that online neurocognitive testing is valid and reliable in a smaller sample of locally recruited participants tested both in-lab and online.

Inclusion: diagnosis of Parkinson's disease by neurologist or healthy individual with no diagnosis of any neurological illness.

Exclusion: Psychotic spectrum disorders, active uncontrolled depression, advanced dementia (i.e. needing assistance with daily activities such as dressing or bathing), major stroke, major head injury, epilepsy requiring anti-seizure medications.

ClinicalTrials.gov NCT05025254